Topotecan (Hycamtin) : A New Option for Second-Line Treatment of Advanced Ovarian Cancer

Author(s)

Bibliographic Information

Topotecan (Hycamtin) : A New Option for Second-Line Treatment of Advanced Ovarian Cancer

guest editor, Maurie Markman

（Seminars in oncology, v. 24, supp. 5）

W.B. Saunders Co., 1997

Available at  / 1 libraries

Search this Book/Journal

Note

Includes bibliographical references

Related Books： 1-1 of 1

Details

  • NCID
    BA37149887
  • Country Code
    us
  • Title Language Code
    eng
  • Text Language Code
    eng
  • Place of Publication
    Philadelphia, Pa.
  • Pages/Volumes
    30 p.
  • Size
    29 cm
  • Parent Bibliography ID
Page Top